• American Clinical Research Services Acquires Elixia, Oxford BioDynamics, King’s College London Collaborate, Recursion’s Supercomputer Ranked, More

    May 29 | Clinical Research News | American Clinical Research Services has acquired Elixia; Oxford BioDynamics and King's College London are teaming up in the immediate follow up of the APIPPRA trial, the largest RA prevention trial to date; Recursion’s BioHive-2 was dubbed No. 35 on the latest TOP500 list of the world’s fastest supercomputers; more. More
  • Follow the Money: Blackstone Launches Portfolio Company, PCORI Approves Funds for CER Studies, Funds Gifted for Alzheimer’s Research, More

    May 28 | Clinical Research News | Blackstone launches the Blackstone Life Sciences portfolio company Uniquity Bio, a clinical-stage drug development company focused on immunology and inflammation; the Patient-Centered Outcomes Research Institute secures approval of funding awards to support new patient-centered comparative clinical effectiveness research studies; Laurence Belfer gifts funds to the University of Texas MD Anderson Cancer Center to strengthen neurodegeneration research through the Belfer Neurodegeneration Consortium, a transformative multi-institutional initiative to advance the study and treatment of Alzheimer’s disease; more. More
  • The Risk-Based Data Management (RBDM) Revolution

    May 24 | Clinical Research News | The clinical trials landscape is evolving with more data, increased investment in personalized medicines and a shift toward decentralized and hybrid clinical trials. At the same time, the industry is attempting to become more efficient and harness new technologies and data science in operations. More
  • Pan-RAS Inhibitor Offers Hope of Improved Pancreatic Cancer Prognosis

    May 22 | Clinical Research News | A consortium of pancreatic cancer researchers sharing information in real time has shown that an oral pan-RAS inhibitor known as RMC-7977, developed by Revolution Medicines, effectively targets the common cancer-causing RAS proteins while minimally impacting normal cells—and did so across a comprehensive range of preclinical models in a series of similar experiments. More
  • Brain Stimulation Device Could Make Precision Mental Health A Reality

    May 21 | Clinical Research News | In the not-too-distant future, disorders of the brain could be treated with the same precision as heart disease and cancer. The means will be a therapeutic brain-computer interface (BCI) the size of a small blueberry for people suffering from treatment-resistant depression that uses a similar type of implant technology as Elon Musk’s Neuralink for helping paralyzed people speak. More
  • Challenges Facing Cell & Gene Therapy Clinical Trials

    May 17 | Clinical Research News | Clinical trials are the bedrock for developing advanced treatments within the life-saving field of cell and gene therapy. Despite significant strides, these trials encounter multi-faceted challenges that threaten to impede the progress of important new therapies. More
  • Clinical Trial Underway for New-and-Improved Prostate Cancer Test

    May 14 | Clinical Research News | Researchers at the University of Michigan (U-M) have developed a urine test for prostate cancer known as MyProstateScore 2.0 (MPS2), now a property of spinoff LynxDx, which they expect to significantly improve upon the performance of existing assays by focusing on clinically significant cancers and capturing more biomarkers in a single test. More
  • How Patient-Mediated Research Can Disrupt Life Sciences

    May 10 | Clinical Research News | The life science industry is changing. There are growing calls for real-world evidence (RWE) and feedback from patients (PROs). Rare diseases are growing in importance, and there is increasing recognition of equity as an ethical and drug-efficacy necessity. More
View more articles
 
DXX-Industry-spotlight
SOT

The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News Senior writer Deborah Borfitz welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.